An early-stage clinical trial of an experimental Ebola vaccine found that the vaccine, called VSV-ZEBOV, was safe and elicited robust antibody responses in all 40 of the healthy adults who received it.
from Latest Science News -- ScienceDaily http://ift.tt/1y0oM7t via Karis World
from Latest Science News -- ScienceDaily http://ift.tt/1y0oM7t via Karis World
No comments:
Post a Comment